The liposomal ubiquinol solutions for Mitochondrial Cytopathies
Cyto-Q and Cyto-Q MAX (ubiquinol) are the only liposomal encapsulated CoQ10 medical foods for the dietary management of Mitochondrial Cytopathies. These liposomal formulations of reduced Co-enzyme Q10 (ubiquinol) have a greater bioavailability and antioxidant role than the conventional ubiquinone used in commercially available CoQ10 preparations.
Cyto-Q and Cyto-Q MAX as Medical Foods
Solace Nutrition has partnered with the leading Coenzyme Q10 manufacturer, Tishcon to develop the Cyto-Q range of formulations. Tishcon has been awarded Orphan Drug (FDA) designated status for Coenzyme Q10 in the treatment of Mitochondrial Cytopathies. Cyto-Q and Cyto-Q MAX are to be used under medical supervision in the dietary management of very rare and serious mitochondrial disorders and other metabolic disorders, where patients are not capable of producing enough coenzyme Q10. Cyto-Q and Cyto-Q MAX must be prescribed by a metabolic specialist or neurologist. Read more
Mitochondrial diseases are a group of disorders relating to the mitochondria, the organelles that are the "powerhouses" of the human cells. The mitochondria convert the energy of food molecules into the ATP that powers most cell functions.
Read more
Benefits of Ubiquinol
- Achievement of higher blood CoQ10 levels using far lower doses
- Excellent safety records
- Decrease in serum lactate
- Improved exercise tolerance
- Increased muscle strength
- Magnetic Resonance Spectroscopy improvements
- As a cellular antioxidant, effectively suppresses free radicals and increases mitochondrial energy production
Ordering Cyto-Q and Cyto-Q MAX - (888) 876-5223
Contact Solace Nutrition
(888) 8-SOLACE (876-5223)
Fax: 401 633-6066
www.solacenutrition.com
Protected one or more of the following US Patents: US – 6,740,338 / 6,455,072 / 6,300,377 / 6,441,050
